Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 91

1.

Conformationally restricted analogs of BD1008 and an antisense oligodeoxynucleotide targeting sigma1 receptors produce anti-cocaine effects in mice.

Matsumoto RR, McCracken KA, Friedman MJ, Pouw B, De Costa BR, Bowen WD.

Eur J Pharmacol. 2001 May 11;419(2-3):163-74.

PMID:
11426838
2.

N-alkyl substituted analogs of the sigma receptor ligand BD1008 and traditional sigma receptor ligands affect cocaine-induced convulsions and lethality in mice.

Matsumoto RR, McCracken KA, Pouw B, Miller J, Bowen WD, Williams W, De Costa BR.

Eur J Pharmacol. 2001 Jan 12;411(3):261-73.

PMID:
11164383
3.

Synthesis and transporter binding properties of bridged piperazine analogues of 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine (GBR 12909).

Zhang Y, Rothman RB, Dersch CM, de Costa BR, Jacobson AE, Rice KC.

J Med Chem. 2000 Dec 14;43(25):4840-9.

PMID:
11123994
4.

A practical approach for repositioning flipped venous access ports.

de Costa BR, Dickey K, Greenwood L.

J Vasc Interv Radiol. 2000 Feb;11(2 Pt 1):213-4. No abstract available.

PMID:
10716392
5.
6.

Two novel sigma receptor ligands, BD1047 and LR172, attenuate cocaine-induced toxicity and locomotor activity.

McCracken KA, Bowen WD, de Costa BR, Matsumoto RR.

Eur J Pharmacol. 1999 Apr 16;370(3):225-32.

PMID:
10334496
7.

Fourphit, an acylating phencyclidine derivative, attenuates cocaine-induced hyperactivity in rats.

Schweri MM, de Costa BR, Rice KC.

Pharmacol Biochem Behav. 1998 Jul;60(3):615-23.

PMID:
9678644
8.

Microinjection of sigma ligands into cranial nerve nuclei produces vacuous chewing in rats.

Tran TT, de Costa BR, Matsumoto RR.

Psychopharmacology (Berl). 1998 May;137(2):191-200.

PMID:
9630006
9.

Subchronic administration of N-[2-(3,4-dichlorophenyl) ethyl]-N-methyl-2-(dimethylamino) ethylamine (BD1047) alters sigma 1 receptor binding.

Zambon AC, De Costa BR, Kanthasamy AG, Nguyen BQ, Matsumoto RR.

Eur J Pharmacol. 1997 Apr 11;324(1):39-47.

PMID:
9137911
10.
12.

Dissociation of the motor effects of (+)-pentazocine from binding to sigma 1 sites.

Matsumoto RR, Bowen WD, Walker JM, Patrick SL, Zambon AC, Vo VN, Truong DD, De Costa BR, Rice KC.

Eur J Pharmacol. 1996 Apr 22;301(1-3):31-40.

PMID:
8773444
13.
14.

Characterization of two novel sigma receptor ligands: antidystonic effects in rats suggest sigma receptor antagonism.

Matsumoto RR, Bowen WD, Tom MA, Vo VN, Truong DD, De Costa BR.

Eur J Pharmacol. 1995 Jul 14;280(3):301-10.

PMID:
8566098
15.

Opioid peptide receptor studies. 3. Interaction of opioid peptides and other drugs with four subtypes of the kappa 2 receptor in guinea pig brain.

Ni Q, Xu H, Partilla JS, de Costa BR, Rice KC, Kayakiri H, Rothman RB.

Peptides. 1995;16(6):1083-95.

PMID:
8532593
16.
17.

GBR12909 attenuates cocaine-induced activation of mesolimbic dopamine neurons in the rat.

Baumann MH, Char GU, De Costa BR, Rice KC, Rothman RB.

J Pharmacol Exp Ther. 1994 Dec;271(3):1216-22.

PMID:
7996429
18.

Dihydrocodeinone-hydrazone, dihydrocodeinone-oxime, naloxone-3-OMe-oxime, and clocinnamox fail to irreversibly inhibit opioid kappa receptor binding.

Ni Q, Xu H, Partilla JS, de Costa BR, Rice KC, Borsodi A, Hosztafi S, Rothman RB.

Neurochem Res. 1994 Sep;19(9):1159-63.

PMID:
7824069
19.

Kappa opioid effects on fetal behavior: central administration of U50,488.

Petrov ES, Varlinskaya EI, Robinson SR, Smotherman WP, de Costa BR, Rice KC.

Physiol Behav. 1994 Jul;56(1):175-82.

PMID:
8084898
20.

Studies of the biogenic amine transporters. IV. Demonstration of a multiplicity of binding sites in rat caudate membranes for the cocaine analog [125I]RTI-55.

Rothman RB, Cadet JL, Akunne HC, Silverthorn ML, Baumann MH, Carroll FI, Rice KC, de Costa BR, Partilla JS, Wang JB, et al.

J Pharmacol Exp Ther. 1994 Jul;270(1):296-309.

PMID:
8035327
21.

Differential effects of systemically administered nor-binaltorphimine (nor-BNI) on kappa-opioid agonists in the mouse writhing assay.

Broadbear JH, Negus SS, Butelman ER, de Costa BR, Woods JH.

Psychopharmacology (Berl). 1994 Jul;115(3):311-9.

22.

Central administration of the endopeptidase 24.15 inhibitor cFP-AAF-pAB suggests dynorphin as the endogenous ligand underlying behavioral effects of milk in the fetal rat.

Smotherman WP, Robinson SR, Varlinskaya EI, Petrov ES, Orlowski M, de Costa BR, Rice KC.

Pharmacol Biochem Behav. 1994 Mar;47(3):715-9.

PMID:
7911578
23.

Studies of the biogenic amine transporters. III. Demonstration of two binding sites for [3H]GBR12935 and [3H]BTCP in rat caudate membranes.

Akunne HC, Dersch CM, Cadet JL, Baumann MH, Char GU, Partilla JS, de Costa BR, Rice KC, Carroll FI, Rothman RB.

J Pharmacol Exp Ther. 1994 Mar;268(3):1462-75.

PMID:
7908058
24.
27.

Effects of sigma ligands on rat cerebellar Purkinje neuron firing: an iontophoretic study.

Martin WJ, De Costa BR, Walker JM.

Brain Res Bull. 1994;35(4):303-9.

PMID:
7850479
29.

Kappa opioid antagonist effects of systemically administered nor-binaltorphimine in a thermal antinociception assay in rhesus monkeys.

Butelman ER, Negus SS, Ai Y, de Costa BR, Woods JH.

J Pharmacol Exp Ther. 1993 Dec;267(3):1269-76.

PMID:
8263790
30.

Convulsive effects of systemic administration of the delta opioid agonist BW373U86 in mice.

Comer SD, Hoenicke EM, Sable AI, McNutt RW, Chang KJ, De Costa BR, Mosberg HI, Woods JH.

J Pharmacol Exp Ther. 1993 Nov;267(2):888-95.

PMID:
8246164
31.

Discriminative stimulus effects of BW373U86: a nonpeptide ligand with selectivity for delta opioid receptors.

Comer SD, McNutt RW, Chang KJ, De Costa BR, Mosberg HI, Woods JH.

J Pharmacol Exp Ther. 1993 Nov;267(2):866-74.

PMID:
8246161
32.
33.
35.
36.

Sigma receptor-mediated emetic response in pigeons: agonists, antagonists and modifiers.

Hudzik TJ, De Costa BR, McMillan DE.

Eur J Pharmacol. 1993 May 19;236(2):279-87.

PMID:
8100532
37.

Identification of a GBR12935 homolog, LR1111, which is over 4,000-fold selective for the dopamine transporter, relative to serotonin and norepinephrine transporters.

Rothman RB, Lewis B, Dersch C, Xu H, Radesca L, de Costa BR, Rice KC, Kilburn RB, Akunne HC, Pert A.

Synapse. 1993 May;14(1):34-9.

PMID:
8511716
38.
39.
40.

Cannabinoid structure-activity relationships: correlation of receptor binding and in vivo activities.

Compton DR, Rice KC, De Costa BR, Razdan RK, Melvin LS, Johnson MR, Martin BR.

J Pharmacol Exp Ther. 1993 Apr;265(1):218-26.

PMID:
8474008
41.

Synthesis and binding characteristics of potential SPECT imaging agents for sigma-1 and sigma-2 binding sites.

He XS, Bowen WD, Lee KS, Williams W, Weinberger DR, de Costa BR.

J Med Chem. 1993 Mar 5;36(5):566-71.

PMID:
8496936
42.
43.

Phenylpiperidine opioid antagonists that promote weight loss in rats have high affinity for the kappa 2B (enkephalin-sensitive) binding site.

Rothman RB, Xu H, Char GU, Kim A, De Costa BR, Rice KC, Zimmerman DM.

Peptides. 1993 Jan-Feb;14(1):17-20.

PMID:
8382809
44.

Sigma receptors and signal transduction: negative modulation of signaling through phosphoinositide-linked receptor systems.

Bowen WD, Tolentino PJ, Kirschner BN, Varghese P, de Costa BR, Rice KC.

NIDA Res Monogr. 1993;133:69-93. No abstract available.

PMID:
8232517
45.
46.

Cocaine and GBR12909 produce equivalent motoric responses at different occupancy of the dopamine transporter.

Rothman RB, Grieg N, Kim A, De Costa BR, Rice KC, Carroll FI, Pert A.

Pharmacol Biochem Behav. 1992 Dec;43(4):1135-42.

PMID:
1475296
47.

[3H] cocaine labels a binding site associated with the serotonin transporter in guinea pig brain: allosteric modulation by paroxetine.

Akunne HC, de Costa BR, Jacobson AE, Rice KC, Rothman RB.

Neurochem Res. 1992 Dec;17(12):1275-83.

PMID:
1461373
49.

Interaction of opioid peptides and other drugs with multiple delta ncx binding sites in rat brain: further evidence for heterogeneity.

Xu H, Partilla JS, de Costa BR, Rice KC, Rothman RB.

Peptides. 1992 Nov-Dec;13(6):1207-13.

PMID:
1337380
50.

Probing the opioid receptor complex with (+)-trans-SUPERFIT. II. Evidence that mu ligands are noncompetitive inhibitors of the delta cx opioid peptide binding site.

Rothman RB, Mahboubi A, Bykov V, Kim CH, de Costa BR, Jacobson AE, Rice KC.

Peptides. 1992 Nov-Dec;13(6):1137-43.

PMID:
1337378

Supplemental Content

Loading ...
Support Center